QC Kinetix: A Trailblazer in Regenerative Medicine, Revolutionizing the Medical Field

QC Kinetix is a fast-growing, highly acclaimed regenerative medicine company that offers innovative, non-surgical solutions for joint and pain relief. Since its inception in 2017, the company has rapidly expanded, establishing operations in over 100 cities nationwide and providing thousands of patients with advanced, non-surgical treatment options.

QC Kinetix employs regenerative medicine therapies that tap into and activate the body’s inherent capacity for self-renewal, enhancing function and offering relief from musculoskeletal discomfort without the need for surgery.

In May 2024, QC Kinetix earned a spot in Entrepreneur’s top 10 2024 Top New and Emerging Franchises, climbing five places to number 9. The magazine highlighted the company’s innovation and its impressive achievements in unit growth, financial strength, stability, and brand power.

The company reported a remarkable 2,111% growth in units over the past three years, positioning them as one of the top-performing brands.

“We’re honored to rank among some of the fastest-growing franchise brands,” the CEO of QC Kinetix stated. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”

QC Kinetix Receives Support from Leading Industry Figures

The company is steadfast in its mission to offer patients a superior option for alleviating pain. QC is motivated by a profound commitment to helping individuals restore their quality of life without relying on pain medications, surgery, or steroids. Their success in treating thousands of patients with innovative biologics treatment protocols underscores their dedication to exceptional patient care.

The company recently appointed the globally distinguished orthopedic surgeon, Dr. Mitchell Sheinkop, as the national medical director at QC Kinetix.

He ushers in a new chapter for the company, leveraging his extensive 37-year background in joint replacement surgery. His choice to join the company demonstrates his conviction in the transformative potential of regenerative medicine and his dedication to patient care.

In his role at QC Kinetix, Dr. Sheinkop will lead the medical management team, concentrating on refining protocols and driving research and development efforts to maintain the franchise’s forefront position in medical innovation. He plans to integrate physical therapy and weight management into the current treatment models to improve patient outcomes and satisfaction, thereby enhancing the overall brand.

As QC Kinetix embarks on an exciting new chapter with Dr. Sheinkop at the helm, his vast experience, which combines remarkable clinical successes with a firm commitment to education and professional development, makes Dr. Sheinkop the ideal leader to guide QC Kinetix towards new heights of success and innovation.

The company also enjoys support from notable athletes, such as Pro Football Hall of Famer Emmitt Smith, who acts as the national spokesperson for QC Kinetix.

“I’ve got to keep taking care of these joints,” Smith said, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”

What Is QC Kinetix?

A medical doctor, a physician assistant, a nurse practitioner, and a business expert all entered a room together.

Fueled by ambition and a dream, they required a name for their new venture. Eager to honor their origins in Charlotte, North Carolina, affectionately known as “the Queen City” (QC), they found the inspiration for the initial part of their company’s name.

“Kinetix” draws from the concept of kinetic energy, which refers to the energy of motion. QC Kinetix’s mission is to restore mobility by leveraging the body’s own cells to promote regeneration.

The creators of QC Kinetix saw a substantial opportunity to revolutionize the conventional approaches to treating musculoskeletal pain. They conceived a modern, safer, and healthier strategy, creating a concierge medical model that employs regenerative medicine to enhance patients’ quality of life. This dedication to pioneering new solutions distinguishes QC Kinetix and fuels their ongoing pursuit to advance the frontiers of regenerative medicine.

Numerous patients suffer from pain that hinders their ability to enjoy activities such as golfing, climbing stairs, or spending active time with their grandchildren. QC Kinetix provides an enhanced treatment approach that sidesteps the use of detrimental medications, toxic steroid injections, and the inherent risks of surgical procedures.

“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” a company spokesperson stated. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”

QC Kinetix Emphasizes a Patient-Focused Treatment Strategy

QC Kinetix stands at the forefront of regenerative medicine, aiding individuals in preserving their active lifestyles through extensive regenerative treatments aimed at managing musculoskeletal and joint pain.

They have effectively treated thousands of patients with distinctive biologics treatment protocols.

QC Kinetix harnesses the body’s innate healing abilities with advanced natural biologic treatments, offering an alternative to invasive surgeries and addictive pain medications.

The clinics focus on enhancing the body’s natural capacity to heal and regenerate from within, significantly improving functionality and overall quality of life.

Patients may arrive experiencing pain in their knees, shoulders, or hips. QC Kinetix utilizes the body’s own natural properties to foster health regeneration. Since its inception, the company has achieved numerous milestones.

In 2023, QC Kinetix surpassed $100 million in system-wide sales, and by April 2024, the company had treated its 40,000th patient, following the start of its national expansion in 2021.

“It is our goal to change medicine,” the CEO of QC Kinetix stated. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”

QC Kinetix Stands on the Brink of a Major Breakthrough

Having established a robust presence in the United States, QC Kinetix is now eyeing global expansion. The brand aims to penetrate markets in the United Kingdom, Australia, and New Zealand shortly, reinforcing its status as a worldwide frontrunner in regenerative medicine.

QC Kinetix has set a goal to reach 250 operational locations across the United States by the close of 2024.

In just four years of franchising, QC Kinetix has achieved remarkable growth. However, the CEO of QC Kinetix expressed that the only surprising aspect is that the expansion hasn’t occurred even more quickly, given the high demand for alternatives to pain medications and surgery. This swift expansion underscores the robust consumer interest in non-surgical pain relief options and the keen attention from franchise investors and operators in the healthcare industry.

“I love this brand and our future,” the CEO of QC Kinetix said.. “It’s about impacting people’s lives and being a game-changer in the medical field.”